Maternal Mental Health Awareness
May 16, 2024
May is Maternal Mental Health Awareness Month!
...
Read More
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia
May 13, 2024
Recent data indicates that upstream muscarinic modulation of downst...
Read More
Esketamine Linked to Reduced Postpartum Depression Risk
May 10, 2024
In a recent meta-analysis, researchers examined whether intravenous...
Read More
NEI Podcast Episode 224 with Dr. Joji Suzuki
May 8, 2024
What are the hypothesized neurobiological mechanisms that support t...
Read More
Telehealth May Help People Stick with Alcoholism Treatment
May 6, 2024
Alcohol use disorder (AUD) is widespread in the United States, yet ...
Read More
High-Dose Valproate Linked to Significant Weight Gain
May 2, 2024
A recent longitudinal study conducted in a psychiatric population h...
Read More
Cyproheptadine-Prazosin Combination for AUD
April 24, 2024
A recent double-blind, parallel group, placebo-controlled Phase 2 c...
Read More
TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Positive Phase 3 Topline Results Evaluating Lumateperone as Adjunctive Therapy for MDD
April 22, 2024
Encouraging results from a Phase 3 clinical trial evaluating lumate...
Read More
Highlights from 2024 NEI Synapse: We Didn’t Write the Rx: A Guide to the Pros and Cons of Complementary and Alternative Medicine
April 21, 2024
Complementary health approaches are commonly used by patients seeki...
Read More
Highlights from 2024 NEI Synapse: Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan
April 20, 2024
One of the most overlooked and underdiagnosed manifestations along ...
Read More
Highlights from 2024 NEI Synapse: The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression
April 19, 2024
Major depressive disorder (MDD) can be difficult to treat and if pa...
Read More